Scenic Biotech
Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.
Amsterdam, Netherlandswww.scenicbiotech.com ↗
Total raised
€28M
€28,000,000
Funding rounds
1
Investors
7
distinct backers
Active since
2022-03
latest 2022-03
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-03-10 | Series A | €28M | BioGeneration Ventures,BioMedPartners,EIR Ventures,Inkef Capital,Nordic Life Science,Oxford Science Enterprises+1 more | View deal → |
Investors
7Related news
- Amsterdam’s Scenic Biotech raises €28M to specialise in evolution-inspired medicine for rare diseasessiliconcanals.com · 2022-03
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- Roivant Sciences€1.2BSwitzerland · Healthtech